Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Nature Communications|February 3, 2023
Myelodysplastic Syndrome associated TET2 mutations affect NK cell function and genome methylationMaxime Boy, Valeria Bisio, Lin-Pierre Zhao, et al.Haematologica|February 2, 2023
Somatic genetic alterations predict hematological progression in GATA2 deficiencyLaetitia Largeaud, Matthew Collin, Nils Monselet, et al.British Journal of Haematology|September 16, 2024
Haematological features of telomere biology disorders diagnosed in adulthood: A French nationwide study of 127 patientsFrançois Maillet, Jacques-Emmanuel Galimard, Raphaël Borie, et al.Haematologica|March 23, 2023
Allogeneic transplantation in acute myelogenous leukemia: a comprehensive single institution's experienceGerard Socie, Jacques-Emmanuel Galimard, Emmanuel Raffoux, et al.Blood Cancer Discovery|January 11, 2023
Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic TP53-Mutant Clonal HematopoiesisRathana Kim, Hugo Bergugnat, Lise Larcher, et al.JCO Precision Oncology|March 25, 2026
Predisposition to ALL and Solid Tumors Rather Than Bone Marrow Failure in FANCM-Associated Fanconi AnemiaFrancesco Pegoraro, Lise Larcher, Rathana Kim, et al.Cell Stem Cell|March 24, 2026
Metabolite-induced DNA damage drives stochastic stem cell loss and clonal hematopoiesisAshley N Kamimae-Lanning, Jill M Brown, Matthias Günther, et al.European Journal of Human Genetics : EJHG|October 3, 2025
Myeloid neoplasms risks for germline DDX41 pathogenic variants carriersMarie-Charlotte Villy, Youenn Drouet, Lise Larcher, et al.Blood|March 22, 2022
Concurrent CDX2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALLMarie Passet, Rathana Kim, Stéphanie Gachet, et al.European Journal of Haematology|July 16, 2025
Eltrombopag for Bone Marrow Failure in Fanconi Anemia: Results From the Phase II Clinical Trial FANCREVJune Iriondo, Josune Zubicaray, Paula Río, et al.Pageof 4